Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCandel Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q2 2024 | 1 | $1.54 | $1.54 | $1.54 |
| Q3 2024 | 1 | -$0.27 | -$0.27 | -$0.27 |
Candel Therapeutics, Inc. Earnings Date And Information
Candel Therapeutics, Inc. last posted its earnings results on Thursday, March 28th, 2024. The company reported $-0.38 earnings per share for the quarter, missing analysts' consensus estimates of $-0.16 by $0.22. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Candel Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.31 diluted earnings per share) and currently has a price-to-earnings ratio of -5.29. Candel Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based on prior year's report dates.
Candel Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.33 | $0 | $0 | ||
| 08/13/2024 | Q2 2024 | -$0.74 | $0 | $0 | ||
| 05/14/2024 | Q1 2024 | -$0.28 | $0 | |||
| 04/25/2024 | Q4 2023 | -$0.38 | $1.78 M | |||
| 11/09/2023 | Q3 2023 | -$0.19 | -$0.29 | -0.1 | $0 | |
| 08/10/2023 | Q2 2023 | -$0.23 | -$0.33 | -0.1 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.35 | -$0.27 | 0.08 | $0 | |
| 03/30/2023 | Q4 2022 | -$0.16 | $0.37 | 0.53 | $31,000 | |
| 11/10/2022 | Q3 2022 | -$0.53 | -$0.29 | 0.24 | $15,500 | $31,000 |
| 08/05/2022 | Q2 2022 | -$0.54 | $0.02 | 0.56 | $31,000 | |
| 05/12/2022 | Q1 2022 | -$0.49 | $0.25 | 0.74 | $31,000 | |
| 03/29/2022 | Q4 2021 | -$0.32 | $0.07 | 0.39 | $31,000 | |
| 11/12/2021 | Q3 2021 | -$0.27 | -$0.69 | -0.42 | $13,333 | $31,000 |
| 09/08/2021 | Q2 2021 | -$0.12 | -$0.69 | -0.57 | $6,667 | $31,000 |
| 03/30/2021 | Q1 2021 | -$0.24 | $31,000 | |||
| 12/30/2020 | Q4 2020 | -$0.56 | $31,000 | |||
| 09/29/2020 | Q3 2020 | -$0.14 | $31,000 | |||
| 06/29/2020 | Q2 2020 | -$0.15 | $31,000 | |||
| 03/30/2020 | Q1 2020 | -$0.09 | $31,000 |
Candel Therapeutics, Inc. Earnings: FAQ's
When is Candel Therapeutics, Inc.'s earnings date?
Candel Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based off last year's report dates.
How can I listen to Candel Therapeutics, Inc.'s earnings conference
call?
The conference call for Candel Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Candel Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Candel Therapeutics, Inc.'s latest earnings report can be read online.
How much profit does Candel Therapeutics, Inc. generate each year?
Candel Therapeutics, Inc. (:CADL) has a recorded net income of $0. Candel Therapeutics, Inc. has generated $-1.31 earnings per share over the last four quarters.
What is Candel Therapeutics, Inc.'s price-to-earnings ratio?
Candel Therapeutics, Inc. (:CADL) has a price-to-earnings ratio of -5.29 and price/earnings-to-growth ratio is 2.24.